Quarterly report [Sections 13 or 15(d)]

Stockholders' Equity - Schedule of Unvested Performance and Time Based Restricted Stock Units (Details)

v3.25.3
Stockholders' Equity - Schedule of Unvested Performance and Time Based Restricted Stock Units (Details) - $ / shares
9 Months Ended
Nov. 02, 2025
Nov. 03, 2024
Performance Shares    
Number of shares    
Number of shares, unvested, beginning balance (in shares) 960,055 812,822
Number of shares, granted (in shares) 330,314 605,263
Number of shares, forfeited (in shares) (217,387) (446,118)
Number of shares, vested (in shares) (30,980)  
Number of shares, unvested, ending balance (in shares) 1,042,002 971,967
Weighted average grant date fair value    
Weighted average grant date fair value, unvested, beginning balance (in dollars per share) $ 23.94 $ 31.01
Weighted average grant date fair value, granted (in dollars per share) 19.87 21.27
Weighted average grant date fair value, forfeited (in dollars per share) 27.06 33.19
Weighted average grant date fair value, vested (in dollars per share) 21.56  
Weighted average grant date fair value, unvested, ending balance (in dollars per share) $ 22.07 $ 23.94
Restricted Stock Units    
Number of shares    
Number of shares, unvested, beginning balance (in shares) 328,947 219,586
Number of shares, granted (in shares) 375,757 241,571
Number of shares, forfeited (in shares) (42,764) (18,465)
Number of shares, vested (in shares) (162,079) (102,786)
Number of shares, unvested, ending balance (in shares) 499,861 339,906
Weighted average grant date fair value    
Weighted average grant date fair value, unvested, beginning balance (in dollars per share) $ 24.96 $ 32.91
Weighted average grant date fair value, granted (in dollars per share) 19.47 21.93
Weighted average grant date fair value, forfeited (in dollars per share) 20.82 26.99
Weighted average grant date fair value, vested (in dollars per share) 26.20 33.08
Weighted average grant date fair value, unvested, ending balance (in dollars per share) $ 20.79 $ 25.38